SIRT1 and metabolic syndrome: Taken together, dyslipidemia in diabetic nephropathy mice was ameliorated by the downregulation of HNF4A and activation of AMPK and SIRT1, which could be related to abnormal lipid metabolism in renal podocytes in diabetic nephropathy.